페닐레프린 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Phenylephrine Drugs Market size is expected to reach USD 54.71 Billion in 2034 from USD 30.16 Billion (2025) growing at a CAGR of 6.84% during 2026-2034.

The global phenylephrine drugs market is experiencing steady growth due to the widespread use of phenylephrine in treating conditions such as nasal congestion, hypotension, and certain eye conditions. Phenylephrine is a commonly used decongestant that works by constricting blood vessels to reduce swelling in nasal passages. It is widely used in cold and flu medications as well as in hospital settings to manage low blood pressure during surgical procedures.

The increasing prevalence of respiratory illnesses and seasonal allergies is driving the demand for phenylephrine-based medications. Pharmaceutical companies are producing various formulations including tablets, nasal sprays, and injectable solutions to meet patient needs. Additionally, the growing availability of over-the-counter medications containing phenylephrine is making treatment more accessible to consumers.

In the future, the market is expected to grow as respiratory infections and allergic conditions continue to affect large populations globally. Pharmaceutical research is focusing on improving drug formulations and delivery methods to enhance treatment effectiveness. As healthcare awareness increases and access to medications improves, phenylephrine drugs will remain widely used in medical treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Tablets
• Syrups
• Eye Drops
• Other Product Types

By Route Of Administration

• Oral
• Parenteral
• Other Routes Of Administration

By Indication

• Cold
• Nasal Decongestion
• Allergic Reaction
• Eye Disease
• Other Indications

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Novartis AG, Perrigo Company PLC, Johnson Johnson Consumer Inc Kenvue Inc, Procter Gamble Co, Pfizer Inc, Foundation Consumer Brands LLC, Mylan NV, Torrent Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHENYLEPHRINE DRUGS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Syrups Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Eye Drops Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Product Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHENYLEPHRINE DRUGS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Routes Of Administration Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHENYLEPHRINE DRUGS MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cold Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Nasal Decongestion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Allergic Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Eye Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHENYLEPHRINE DRUGS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Drug Stores & Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHENYLEPHRINE DRUGS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Route Of Administration
  • 8.2.3 By Indication
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Route Of Administration
  • 8.3.3 By Indication
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Route Of Administration
  • 8.4.3 By Indication
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Route Of Administration
  • 8.5.3 By Indication
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Route Of Administration
  • 8.6.3 By Indication
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PHENYLEPHRINE DRUGS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Novartis AG
  • 10.2.2 Perrigo Company PLC
  • 10.2.3 Johnson & Johnson Consumer Inc. (Kenvue Inc.)
  • 10.2.4 Procter & Gamble Co
  • 10.2.5 Pfizer Inc
  • 10.2.6 Foundation Consumer Brands LLC
  • 10.2.7 Mylan N.V
  • 10.2.8 Torrent Pharmaceuticals Inc
  • 10.2.9 GlaxoSmithKline PLC
  • 10.2.10 Bayer AG